Last Updated on October 25, 2024 by The Health Master
DGFT
The Directorate General of Foreign Trade (DGFT) has taken a significant step towards modernizing and simplifying pharma export processes with the introduction of an electronic submission system for Appendix 4H certificates.
This digital transformation, outlined in Trade Notice No. 21/2024-25, eliminates paper-based procedures and streamlines the process for both exporters and Certifying Authorities (CAs).
Goodbye Paperwork, Hello Efficiency
Previously, exporters had to submit physical Appendix 4H certificates, documenting the consumption and stock of duty-free imported or domestically sourced raw materials under Advance Authorization (AA) and Duty-Free Import Authorization (DFIA) schemes.
This new electronic system mandates digital submissions, ensuring:
- Reduced Paperwork: Eliminates the need for physical documents, saving time and resources.
- Enhanced Security: Digitally signed certificates minimize the risk of fraud and manipulation.
- Improved Efficiency: Streamlines workflows for faster processing and approvals.
A Seamless Process for All
The new system facilitates a collaborative and efficient process for both exporters and CAs:
Exporters:
- Online Form Filling: Fill in the Appendix 4H form directly on the DGFT website while applying for AA redemption or DFIA Transferable Scrip.
- Seamless Collaboration: Securely forward the draft form electronically to the registered CA for verification and digital signing.
- Real-time Tracking: Track the status of the application and access digitally signed certificates through the online repository.
Certifying Authorities (CAs):
- Registration with DGFT: Register with DGFT to manage, modify, and digitally sign Appendix 4H certificates for assigned exporters.
- Digital Signing: Utilize Aadhaar e-sign or a Digital Signature Token for secure and efficient document verification and signing.
- Improved Client Management: Manage multiple clients and their certificates through a single platform.
Support for a Smooth Transition
For a smooth transition to the digital system, the DGFT has provided comprehensive resources:
- User Guide and FAQs: Access detailed instructions and answers to frequently asked questions on the DGFT website.
- Outreach Programs: Attend informative workshops and programs to gain a deeper understanding of the new processes.
- Helpdesk Support: Contact the DGFT toll-free helpdesk or submit queries via the online portal for assistance.
Advancing India’s Trade Ecosystem
This initiative aligns with the Government of India’s vision of fostering a digital trade environment.
By promoting ease of doing business and efficient export processes, the DGFT is empowering exporters to:
- Maintain Global Competitiveness: Ensure efficient compliance with international trade regulations and procedures.
- Reduce Errors and Delays: Minimize the risk of errors associated with manual paperwork and expedite approvals.
- Embrace Transparency: Enhance transparency throughout the export process for both exporters and authorities.
Embracing these digital changes is crucial for both exporters and CAs to thrive in the evolving trade landscape.
By adopting the new electronic submission system for Appendix 4H certificates, exporters can ensure they remain agile and future-proof in the global marketplace.
For further details, please visit the DGFT website.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Pharma Export: Implementation of Track and Trace system extended
Unlocking Opportunities: Pharmexcil Urges Exporters to Embrace DGFT Amnesty Scheme
DTAB agrees with proposal to amend New Drugs and Clinical Trials Rules
Drug recall: Gilead recalled this drug after failed trial
FSSAI: Food Labelling and Display – Chapter-11
USFDA approval granted for Fludrocortisone Acetate Tablets
Gujarat FDCA empowers Officers to enforce Revised Schedule M
Govt asks NPPA to recalculate ceiling price of Thiamine Injection
DTAB recommends changes to New Drugs and Clinical Trials Rules
NPPA revised Ceiling price of 11 scheduled formulations: October 2024
New Drugs, Medical Devices and Global Standards: India’s Regulatory Advancements
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
